SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-15-172037
Filing Date
2015-05-05
Accepted
2015-05-05 16:06:36
Documents
6
Effectiveness Date
2015-05-05

Document Format Files

Seq Description Document Type Size
1 DEFA14A d887810ddefa14a.htm DEFA14A 38383
2 GRAPHIC g887810g11x75.jpg GRAPHIC 1324
3 GRAPHIC g887810g51r42.jpg GRAPHIC 1582
4 GRAPHIC g887810g59k51.jpg GRAPHIC 1313
5 GRAPHIC g887810g89z77.jpg GRAPHIC 1312
6 GRAPHIC g887810na_xxx.jpg GRAPHIC 1382
  Complete submission text file 0001193125-15-172037.txt   49776
Mailing Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139
Business Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139 617-551-9600
Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36395 | Film No.: 15832984
SIC: 2834 Pharmaceutical Preparations